SY102 / Tasly - LARVOL DELTA

Bioactive Peptide-Enriched Requeson: A Functional Dairy Product From Whey Fermentation. (PubMed, Food Sci Nutr) - "bulgaricus NCFB 2772 and Streptococcus thermophilus SY-102) and a co-culture of both strains, cultured in sweet whey...These findings suggest that LAB co-culture fermentation of sweet whey is an effective strategy to develop peptide-enriched functional Requeson cheese with health-promoting properties. This approach supports the sustainable use of dairy by-products and contributes to the advancement of functional dairy products in the bioeconomy."

Journal

SY102 - The future of clinical phage susceptibility testing (ESCMID Global 2026) - "However, the methods employed for phage susceptibility testing vary between laboratories and centres and no standardisation or reference method is available yet. The purpose of the session is to compare the published recommendations of the European Pharmacopeia on "phage potency testing" for phage products to the clinical susceptibility testing approach on one hand, and on the other hand, to explore current efforts by the EUCAST phage susceptibility sub-committee towards the development of a standard method and a common framework for phage susceptibility testing."

Clinical • Infectious Disease

SY102. Oxygen Delivery: Why Blood Pressure Alone Is Not Enough (non-CME) (ASA 2024) - "In this symposium, we'll explore advanced monitoring tools available to help clinicians ensure optimal tissue perfusion. Masimo, Corporate Supporter"

ACE-Inhibitory Activity of Whey Proteins Fractions Derived of Fermentation by Lacticaseibacillus rhamnosus GG and Streptococcus thermophilus SY-102. (PubMed, Foods) - "The higher inhibition activity, which increased at the conclusion of the fermentation with the co-culture and reached 53.42%, was influenced by the higher peptide synthesis. These findings highlighted the significance of creating useful co-culture products."

Journal

SY102. Emerging Trends in IVF (ENDO 2023) - "DESCRIPTION This session will provide an update on translational and clinical advances in IVF, highlighting new and emerging therapies and discussing trends in the management of concurrent endocrine diseases including obesity, diabetes, thyroid, and neuroendocrine disorders during IVF."

Diabetes • Endocrine Disorders • Genetic Disorders • Metabolic Disorders • Obesity